Development of antiproliferative nanohybrid compound with controlled release property using ellagic acid as the active agent
Mohd Zobir Hussein1,2, Samer Hasan Al Ali2, Zulkarnain Zainal2, Muhammad Nazrul Hakim31Advanced Materials and Nanotechnology Laboratory, Institute of Advanced Technology (ITMA), 2Department of Chemistry, Faculty of Science, 3Department of Biomedical Science, Faculty of Medicine and Health Science, U...
Guardado en:
Autores principales: | Hussein MZ, Al Ali SH, Zainal Z, Hakim MN |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/58f6b7ae817a46a5a8f747875d10d0e7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Preparation of hippurate-zinc layered hydroxide nanohybrid and its synergistic effect with tamoxifen on HepG2 cell lines
por: Hussein Al Ali SH, et al.
Publicado: (2011) -
Anticancer nanodelivery system with controlled release property based on protocatechuate–zinc layered hydroxide nanohybrid
por: Barahuie F, et al.
Publicado: (2014) -
Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite
por: Hussein Al Ali SH, et al.
Publicado: (2012) -
Controlled-release formulation of antihistamine based on cetirizine zinc-layered hydroxide nanocomposites and its effect on histamine release from basophilic leukemia (RBL-2H3) cells
por: Hussein Al Ali SH, et al.
Publicado: (2012) -
Presynaptic Release-Regulating Alpha2 Autoreceptors: Potential Molecular Target for Ellagic Acid Nutraceutical Properties
por: Isabella Romeo, et al.
Publicado: (2021)